Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 765 across all filing types
Latest filing 2025-04-03 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025
Regulatory Filings Classification · 1% confidence The document is titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities” and comprises a statutory exchange filing (Form FF301) reporting authorised and issued share capital and treasury share movements for the month ended 31 March 2025. It is a routine regulatory disclosure under the HKEX Listing Rules rather than an ad-hoc capital raising announcement, financial report, or proxy statement. It does not itself announce any dividend, M&A, or management change, and it provides the full return rather than simply announcing the publication of another report. Therefore it best fits the “Regulatory Filings” fallback category.
2025-04-03 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount Classification · 1% confidence The document is a cash dividend announcement (“Final dividend for the year ended 31 December 2024”) detailing dividend type, amount per share, important dates (ex‐dividend, record, payment), and related registrar information. This matches the definition of a Notice of Dividend Amount (DIV).
2025-03-28 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release Classification · 1% confidence The document is titled “ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024” and presents key financial highlights, segment revenues, profit metrics, and dividend recommendations in a narrative format. It reads like an earnings release rather than the full statutory annual report. It does not contain full audited financial statements, notes, or regulatory forms typical of an Annual Report (10-K) or Audit Report. It is a company’s results announcement, matching the Earnings Release category. FY 2024
2025-03-28 English
OVERSEAS REGULATORY ANNOUNCEMENT - RESULTS OF A SUBSIDIARY
Earnings Release Classification · 1% confidence The document is a Hong Kong Stock Exchange regulatory announcement under Rule 13.10B disclosing the first quarter 2025 financial estimates of a non-wholly owned subsidiary, providing only high-level revenue and profit figures. It is a preliminary earnings announcement (业绩预告) rather than a full interim report. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results with key highlights only). Q1 2025
2025-03-27 English
VOLUNTARY ANNOUNCEMENT - PROGRESS ON THE SUBSEQUENT LISTING OF SICHUAN RUIJIAN MEDICAL ON BEIJING STOCK EXCHANGE
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement by PW Medtech Group Limited regarding progress on the proposed listing of its subsidiary, Sichuan Ruijian Medical, on the Beijing Stock Exchange. It does not present financial results, proxy materials, dividend notices, or any formal report; rather, it is a corporate development update under exchange rules. It therefore falls under the general Regulatory Filings category as a miscellaneous announcement (RNS).
2025-03-25 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a short announcement (1,368 characters) notifying shareholders of the date of a Board meeting to approve and publish the annual results and consider a dividend. It does not contain actual results or detailed financial data but merely schedules the approval/publication of a report. This fits the definition of “Report Publication Announcement” (RPA), which covers announcements about the timing or release of company reports.
2025-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.